Medical Diagnostics Market in India 2014

Published: Oct, 2014 | Pages: 71 | Publisher: Netscribes
Industry: Healthcare | Report Format: Electronic (PDF)

Netscribes' latest market research report titled Medical Diagnostics Market in India 2014 analyses the growth of the market due to cutting edge technology which provides better disease diagnosis. The Indian diagnostics market can be divided into equipment, reagents and services. The service sector is characterized by a large number of laboratories in the unorganized sector, which are clustered in the suburban areas and metros. In order to have better regulations and proper definition for the market a clear and structured format is being established. The laboratories are rapidly expanding using various business models. Large numbers of laboratories are registered only with the state health departments and not recognized by NABL (National Accreditation Board for Testing and Calibration Laboratories under Department of Science and Technology, Govt. of India).

The market is driven by increasing number of lifestyle diseases, rise in life expectancy due to preventive healthcare practices and increasing medical tourism. Currently there is trend of diagnostic medical imaging due to innovation in the technology sector which is helping the market to grow. Few numbers of accredited labs and high dependence on imported medical diagnostics products are the challenges this market is facing. Even though a range of diagnostic tests for various diseases are available in the market, there is a need for more reliable and better diagnostics. The market is dominated by private diagnostics companies in India who are expanding in Tier I and Tier II cities. Providing after-sales services for medical instruments and competitive pricing of the tests will catalyze the growth of the diagnostic sector.

 Table of Contents
Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 - Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 - Jul 2013), Exchange Rate: Half Yearly (Aug 2013 - Jan 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2009-10, 2010-11, 2011-12, 2012-13), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction
Slide 5: Medical Diagnostics Sector - Overview 

Market Overview 
Slide 6: Medical Diagnostics- Market Overview Forecasted Market Size and Growth (Value-Wise; 2013 - 2018e)
Slide 7: Medical Diagnostics Market - Overview of Franchise Business Model
Slide 8: Medical Diagnostics Market - Overview of Other Business Models
Slide 9: Accreditation of Laboratories
Slide 10: Technological Developments Used for the Diagnosis of a Wide Spectrum of Infectious Diseases

Drivers & Challenges 
Slide 11: Medical Diagnostics Market - Drivers and Challenges summary
Slide 12-16: Drivers
Slide 17-18: Challenges 
 
Trends
Slide 19: Trends - Summary
Slide 20-22: Trends

Government Regulations
Slide 23: Overview of various Government Regulations

Competitive Landscape
Slide 24: Porter's Five Forces Analysis
Slide 25-28: Competitive Benchmarking (FY 2013)
Slide 29-32: Major Public Player
Slide 33-68: Major Private Players

Strategic Recommendations
Slide 69-70: Strategic Recommendations

 Appendix
Slide 71: Ratio and Calculations and Secondary Research

List of Tables
Market Overview
1. Benefits of Franchise Model
2. Business Model - Green field labs : Advantages and Disadvantages
3. Business Model - Tie ups : Advantages and Disadvantages
4. Business Model - Franchise : Advantages and Disadvantages
5. Business Model - Acquiring Labs : Advantages and Disadvantages
6. Advantages of accreditation
7. Types of Diagnostics, Consumption and Trends and Types of Testing

Drivers and Challenges
1. Advantages of Medical Tourism
2. Transactions

Government Regulations
1. Purview of NABL
2. Measure and Impact of Budget 2014-15

Competitive Landscape
1. Company Profiles (All Companies)
a. Company Information (All Companies)
b. Products and Services (All Companies)
c. Key People (All Companies)
d. Shareholders of the Company (Private Companies)
e. Key Financial Performance Indicators (Public Companies)
f. Key Ratios (All Companies)
g. Business Highlights (All Companies)

Appendix
1. Key Ratio Descriptions
2. Secondary Research
3. Primary Research